Literature DB >> 30416617

Inferior vena cava thrombus due to hyperhomocysteinemia.

Munekazu Tanaka1, Tomohiko Taniguchi1, Naritatsu Saito1, Takeshi Kimura1.   

Abstract

We report a case of a 39-year-old man with inferior vena cava (IVC) thrombus after withdrawal of IVC filter. He complained of 1-week history of swelling in his right leg, and computed tomography (CT) demonstrated occlusive thrombus in right femoral and popliteal veins. Venous thrombectomy was attempted after IVC filter placement. The filter was withdrawn without IVC filter-associated thrombus and the patient was discharged on warfarin. On day 21 after discharge, he complained of progressive swelling and CT revealed a significant amount of thrombus in IVC where the filter had been placed. Despite adequate anticoagulant therapy, CT showed increased thrombus extending from infra-renal IVC to common iliac vein. Systemic work-up for the risk factors of venous thromboembolism revealed the presence of hyperhomocysteinemia (total homocysteine 83.1 μmol/L; normal range 5-15 μmol/L) due to unbalanced diet with deficiency of folic acid and vitamin B12. Four weeks after administration of folic acid, vitamin B6/B12 as the treatment of hyperhomocysteinemia in addition to warfarin, swelling of his leg improved with significant resolution of thrombus by CT. CT also demonstrated a severe stenosis of the IVC just below the renal veins. At 6 months, he complained of mild post-thrombotic sequelae with no evidence of recurrent IVC thrombus. <Learning objective: Hyperhomocysteinemia is associated with higher risk for venous thromboembolism as well as atherosclerotic diseases. Serum homocysteine level is partly explained by genetic background as well as dietary deficiency of folic acid or vitamin B6/B12. Hyperhomocysteinemia is related with low intake of vegetables and seafood. We should be aware of hyperhomocysteinemia when the thrombus increased despite optimal anticoagulant therapy. B vitamins and folic acid therapy might be effective in patients with severe hyperhomocysteinemia.>.

Entities:  

Keywords:  B vitamins; Folic acid; Hyperhomocysteinemia; Inferior vena cava filter; Inferior vena cava thrombus

Year:  2018        PMID: 30416617      PMCID: PMC6218372          DOI: 10.1016/j.jccase.2018.07.003

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  7 in total

1.  Plasma homocysteine levels and mortality in patients with coronary artery disease.

Authors:  O Nygård; J E Nordrehaug; H Refsum; P M Ueland; M Farstad; S E Vollset
Journal:  N Engl J Med       Date:  1997-07-24       Impact factor: 91.245

2.  Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.

Authors:  Martin den Heijer; Huub P J Willems; Henk J Blom; Wim B J Gerrits; Marco Cattaneo; Sabine Eichinger; Frits R Rosendaal; Gerard M J Bos
Journal:  Blood       Date:  2006-09-07       Impact factor: 22.113

3.  Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial.

Authors:  Patrick Mismetti; Silvy Laporte; Olivier Pellerin; Pierre-Vladimir Ennezat; Francis Couturaud; Antoine Elias; Nicolas Falvo; Nicolas Meneveau; Isabelle Quere; Pierre-Marie Roy; Olivier Sanchez; Jeannot Schmidt; Christophe Seinturier; Marie-Antoinette Sevestre; Jean-Paul Beregi; Bernard Tardy; Philippe Lacroix; Emilie Presles; Alain Leizorovicz; Hervé Decousus; Fabrice-Guy Barral; Guy Meyer
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

4.  Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.

Authors:  Joel G Ray; Clive Kearon; Qilong Yi; Patrick Sheridan; Eva Lonn
Journal:  Ann Intern Med       Date:  2007-04-30       Impact factor: 25.391

5.  Homocysteine lowering with folic acid and B vitamins in vascular disease.

Authors:  Eva Lonn; Salim Yusuf; Malcolm J Arnold; Patrick Sheridan; Janice Pogue; Mary Micks; Matthew J McQueen; Jeffrey Probstfield; George Fodor; Claes Held; Jacques Genest
Journal:  N Engl J Med       Date:  2006-03-12       Impact factor: 91.245

6.  Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease.

Authors:  J G Ray
Journal:  Arch Intern Med       Date:  1998-10-26

Review 7.  Indications for thrombolysis in deep venous thrombosis.

Authors:  P Gogalniceanu; C J C Johnston; U Khalid; P J E Holt; R Hincliffe; I M Loftus; M M Thompson
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-05-07       Impact factor: 7.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.